Ireland - English - HPRA (Health Products Regulatory Authority)

gedeon richter plc - estradiol - vaginal tablet - 10 microgram(s) - estradiol

Ireland - English - HPRA (Health Products Regulatory Authority)

sun pharmaceutical industries europe b.v. - estradiol - vaginal tablet - 10 microgram(s) - estradiol

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - estradiol hemihydrate - film-coated tablet - 2 milligram(s) - natural and semisynthetic estrogens, plain; estradiol

Israel - English - Ministry of Health

bayer israel ltd - cyproterone acetate - tablets - cyproterone acetate 10 mg - cyproterone - cyproterone - treatment of pronounced signs of virilisation in women, which make hormone therapy necessary:• severe forms of acne, when it is accompanied by inflammation and the formation of nodes (acne papulopustulosa, acne nodulocystica) or if there is a risk of scarring,• moderate to severe forms of hirsutism,• moderate to severe forms of androgenic alopecia.cyproterone acetate 10 mg is indicated for pronounced signes of virilisation in women, which make hormone therapy necessary if satisfactory results could not be obtained with medicinal products containing low-dose cyproterone or with other treatment options. when treating acne, hormone treatment should be weighed against systemic antibiotic treatment

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - anastrozole - tablet, film coated - 1 mg - anastrozole 1 mg

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - lovastatin (unii: 9lhu78oqfd) (lovastatin - unii:9lhu78oqfd) - lovastatin 20 mg - therapy with lovastatin tablets usp should be a component of multiple risk factor intervention in those individuals with dyslipidemia at risk for atherosclerotic vascular disease. lovastatin tablets usp should be used in addition to a diet restricted in saturated fat and cholesterol as part of a treatment strategy to lower total-c and ldl-c to target levels when the response to diet and other nonpharmacological measures alone has been inadequate to reduce risk. primary prevention of coronary heart disease in individuals without symptomatic cardiovascular disease, average to moderately elevated total-c and ldl-c and below average hdl-c, lovastatin tablets usp are indicated to reduce the risk of: -myocardial infarction -unstable angina -coronary revascularization procedures (see clinical pharmacology, clinical studies). coronary heart disease lovastatin tablets usp are indicated to slow the progression of coronary atherosclerosis in patients with coronary heart disease as part of a treatment strategy to lower

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sovereign medical ltd - gliclazide - oral tablet - 80mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - anastrozole - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - anastrozole - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

relonchem ltd - gliclazide - oral tablet - 80mg